Patients needing NO donor therapy or inhibition of pathologically proliferating cells or increased NO bioactivity are treated with a therapeutically effective amount of an inhibitor of glutathione-dependent formaldehyde dehydrogenase.

 
Web www.patentalert.com

< Use of Saccharomyces cerevisiae erg4 mutants for expressing mammalian glucose transporter

> Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders

> 1,4-benzothiazepine 1,1-dioxide derivative, process for its preparation, medicaments comprising this compound, and use thereof as a hypolipidaemic
~ 00558